CTSA Renewal Celebration

From left: Jonathan Holloway, President, Rutgers University; Mark Manigan, CEO, RWJBarnabas Health; Brian Strom, Chancellor, Rutgers Health; Governor Phil Murphy; Shawna Hudson, Vice Chancellor for Translational Medicine and Science Director, Rutgers Health; Reynold Panettieri, Vice Chancellor for Translational Medicine and Science, Rutgers Health. Photo: Luca Mostello

NJ ACTS Receives 7-year Grant Renewal of $39.7M

Translating scientific discoveries  into improved health in New Jersey and beyond 

 

Join Our Clinical Research Investigator Registry

The Registry can match investigators with new clinical trial opportunities!

 

Advancing clinical and translational science to develop new therapies and treatments and improve health care

Become a Member

NJ ACTS is dedicated to leading the development of new approaches to the health problems of New Jersey and to translating those advances into therapies and treatments.

Find a Clinical Trial

Rutgers supports nearly 350 clinical trials at any given time. Our Rutgers Clinical Research Organization is the gateway to our statewide clinical trial activities

Funding Opportunities

NJ ACTS disseminates information on funding opportunities to its members and partner institutions, directly through emails and our website.

NJ ACTS Services & SRB

NJ ACTS Cores offer consulting, tools and other services to its members and partner institutions.

EVENTS


NEWS


Modernizing Health Records for the Most Vulnerable.

Modernizing Health Records for the Most Vulnerable.

Over a decade ago, an NJIT health care startup took up a daunting challenge: to train 5,000 primary care providers in the state to adopt electronic health record systems that would allow them to better track their patients, improve their quality of care and securely...

VIDEO HIGHLIGHTS